(MENAFN- Market Press Release) January 17, 2022 12:19 pm - The 'Global Microscopic Polyangiitis (MPA) Treatment Market' is predicted to grow at a high CAGR of 5.5% during the forecasting period ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2017" report to their offering. Pharmaceutical and Healthcare ...

New York, United States , April 26, 2023 (GLOBE NEWSWIRE) -- The Global Microscopic Polyangiitis (MPA) Market Size is To Grow by 2032, at a Compound Annual Growth Rate (CAGR) of 5.9% during the ...

Rituxan label updated to include information for follow up treatment in adult patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) who have achieved disease control ...

The report by Gal and Velasquez (1) analyzes the value of tests for anti-neutrophil cytoplasmic antibodies (ANCA) in the diagnosis of Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA) ...

Key Microscopic Polyangiitis Companies in the market include - Genentech, Vifor Pharma, InflaRx GmbH, GlaxoSmithKline, InflaRx GmbH, Hoffmann-La Roche, Novartis, and others. DelveInsight’s ...

(RTTNews) - Vasculitis, which refers to inflammation of the blood vessels, is an autoimmune disease wherein the immune system attacks the body's own cells for unknown reasons. There are approximately ...

The approval for follow up treatment was based on data from an open-label, prospective, active-controlled study (MAINRITSAN) involving 115 patients in disease remission (86 with GPA, 24 with MPA, 5 ...

SAN CARLOS, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Kissei Pharmaceutical Co., Ltd. has received approval ...

Please provide your email address to receive an email when new articles are posted on . CLEVELAND — Ulrich Specks, MD, professor of medicine at the Mayo Clinic College of Medicine, described unmet ...